Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Depreciation and Depletion (2016 - 2020)

Historic Depreciation and Depletion for Assembly Biosciences (ASMB) over the last 6 years, with Q4 2020 value amounting to $300000.0.

  • Assembly Biosciences' Depreciation and Depletion rose 20000.0% to $300000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $600000.0, marking a year-over-year increase of 5000.0%. This contributed to the annual value of $500000.0 for FY2023, which is 0.0% changed from last year.
  • Assembly Biosciences' Depreciation and Depletion amounted to $300000.0 in Q4 2020, which was up 20000.0% from $100000.0 recorded in Q3 2020.
  • Over the past 5 years, Assembly Biosciences' Depreciation and Depletion peaked at $300000.0 during Q4 2020, and registered a low of $18000.0 during Q2 2016.
  • For the 5-year period, Assembly Biosciences' Depreciation and Depletion averaged around $93965.4, with its median value being $100000.0 (2018).
  • Per our database at Business Quant, Assembly Biosciences' Depreciation and Depletion soared by 52664.49% in 2018 and then plummeted by 5000.0% in 2019.
  • Assembly Biosciences' Depreciation and Depletion (Quarter) stood at $24750.0 in 2016, then skyrocketed by 204.34% to $75324.0 in 2017, then soared by 32.76% to $100000.0 in 2018, then changed by 0.0% to $100000.0 in 2019, then surged by 200.0% to $300000.0 in 2020.
  • Its Depreciation and Depletion was $300000.0 in Q4 2020, compared to $100000.0 in Q3 2020 and $100000.0 in Q2 2020.